Ulcerative Colitis (UC)

April 5, 2016April 5, 2016

Crohn’s and Colitis Canada Links IBD Research with Patient Care in Vital Expansion Network

News

Crohn’s and Colitis Canada announced that its pioneering work to bridge pan-Canadian inflammatory bowel disease (IBD) research with patient care is moving forward with the launch of a Strategy for Patient-Oriented Research ... Read more

April 4, 2016May 17, 2016

Crohn’s & Colitis Foundation Elects 5 New Trustees to Join National Board

Crohn's Disease, IBD News, News, Ulcerative colitis

The Crohn’s & Colitis Foundation of America (CCFA) recently announced Donald Kortz, Mark Murray, Marcy Nanus, Joseph Nemmers and Robert “Van” Pulley as the most recent members of the foundation’s ... Read more

March 16, 2016September 28, 2016

Ulcerative Colitis IND Trial Application Cleared by FDA for InDex’s Cobitolimod

IBD News, News, Ulcerative colitis

The U.S. FDA has cleared InDex Pharmaceuticals AB’s Investigational New Drug (IND) application to launch a Phase 2b clinical trial for cobitolimod (Kappaproct) in patients with moderate to severe ulcerative colitis (UC). ... Read more

February 25, 2016May 17, 2016

Possible Treatment for Ulcerative Colitis: Common Vinegar

IBD News, News, Ulcerative colitis

New research has investigated the therapeutic power of vinegar – a common ingredient in the Mediterranean diet – in the fight against ulcerative colitis (UC), an inflammatory bowel disease (IBD) that researchers think ... Read more

February 10, 2016February 10, 2016

Ulcerative Colitis Disease Activity: Rectosigmoidoscopy Strongly Correlates With Colonoscopy Results

IBD News, News, Ulcerative colitis

In a new study, researchers compared the efficacy of two techniques, rectosigmoidoscopy and colonoscopy, for the measurement of endoscopic healing in patients with ulcerative colitis, and found a strong correlation ... Read more

December 28, 2015December 28, 2015

Ulcerative Colitis Study Aims to Restore a Healthy Balance in Gut Bacteria

News

Seres Therapeutics, Inc., a company focused on the development of drugs targeting the unhealthy microbiome for the treatment of inflammatory, metabolic and infectious diseases, recently announced the initiation of a ... Read more

September 17, 2015September 17, 2015

Type I IFNs Incapable of Inducing Remission in Ulcerative Colitis

News

In a recent review study entitled “Type I interferons for induction of remission in ulcerative colitis”, the authors revised clinical studies and concluded that type I interferon therapy, successfully used in ... Read more